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Background: Solitary fibrous tumor (SFT) is rare soft tissue tumor, and it occurs most commonly in the pleura.
Retroperitoneal SFT is generally found by palpable mass or abdominal distention. Here we report a case of SFT
presenting pollakiuria.
Case presentation: A 64-year-old man was referred to our hospital for pollakiuria. Contrasted-enhanced computed
tomography revealed a heterogeneously enhanced pelvic tumor of approximately 10 × 8 × 7 cm. Invasion of the
surrounding organs, distal metastasis, and lymph node swelling were absent. Therefore, surgical resection was
performed. The resected specimen was a 13 × 8 × 5.5-cm encapsulated elastic hard tumor weighing 420 g.
Histologically, the tumor consisted of oval or spindle cells growing in a random manner in a collagenous matrix.
Immunohistochemically, the specimen was positive for CD34, bcl-2, as well as vimentin and negative for c-kit. On
the basis of these findings, a retroperitoneal solitary fibrous tumor (SFT) of the pelvis was diagnosed.
Conclusion: Surgery is the primary treatment for SFT, and pathologically negative margins are important for
good prognosis.
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Solitary fibrous tumor (SFT) is rare soft tissue tumor ini-
tially reported by Klemperer et al. [1]. It occurs most
commonly in the pleura; however, extrathoracic SFT has
also been reported [2-4]. Several cases of retroperitoneal
soft tissue pelvic tumor have been reported [5]. SFT can
be diagnosed preoperatively only by needle biopsy [6]
because it is a rare lesion and not easily recognizable. In
addition, no specific tumor markers have been identified
or images published for this tumor type. We report a
case of retroperitoneal SFT of the pelvis in a patient with
pollakiuria. In this report, a review of related literature is
also provided.
Case presentation
A 64-year-old man with a pacemaker for sick sinus syn-
drome complained of pollakiuria 5 months before
presenting at our hospital. Results of abdominal examin-
ation were normal, and no palpable tumor or enlarged
lymph node was found in the neck, abdomen, axilla, or* Correspondence: ttsushimi@yahoo.co.jp
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reproduction in any medium, provided the oringuinal regions. No abnormal findings were obtained
from blood and urine examinations. Tests for carci-
noembryonic antigen, alpha-fetoprotein, cancer antigen
(CA) 19–9, CA125, and squamous cell carcinoma mar-
kers were all normal. Ultrasonography revealed a
10 × 8 × 6-cm low-echoic mass and a high-echoic region
in the lower abdomen. Cystic regions were also
observed. Contrasted-enhanced computed tomography
(CE-CT) demonstrated a 10 × 8 × 7-cm moderately
lobulated, internal, heterogeneous tumor with hypervas-
cular regions; however, no calcification or fatty compo-
nents were detected. Bladder compression by the tumor
was observed. The tumor border was clear, and no evi-
dence of direct invasion was detected (Figure 1a, b).
CE-CT also revealed no liver or lung metastasis or
intra-abdominal lymph node enlargement. Therefore,
surgery was performed.
The tumor was found in the retroperitoneal pelvic area
below the mesentery of the sigmoid colon. No intestinal
adhesion or tumor invasion of the bladder or other
organs was observed. Resection proceeded uneventfully.
Operating time was 1 h 59 min, and intraoperative blood
loss was found to be 241 ml. A 13 × 8.0 × 5.5-cm, 420-g,al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 CT showed a 10 × 8 × 7-cm, heterogeneously CE pelvic tumor that was slightly lobulated and included hypervascular regions.
(a) Transverse view. (b) Coronal view. T: tumor, B: bladder.
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membrane was excised. The cut surface was grayish-
white and included a cystic component and hemorrhagic
focus (Figure 2a, b). Pathologically, the tumor contained
oval or spindle cells growing in a random pattern in a
collagenous matrix (patternless pattern) (Figure 3a, b).
Surgical margins were negative. Immunohistochemically,
the specimen was positive for CD34, bcl-2, as well as
vimentin, but negative for c-kit (Figure 4a–d). Immuno-
histochemical tests for p53, S-100, and alpha-smooth
muscle actin were all negative. On the basis of these
findings, retroperitoneal SFT of the pelvis was diag-
nosed. The postoperative course was uneventful, and
pollakiuria immediately disappeared. Discharge occurred
on postoperative day 10. No recurrence has been
detected 20 months after surgery.
SFT is a soft tissue tumor first identified in the pleura
by Klempler et al. in 1931 [1]. It is most common in the
pleura, as demonstrated by Gold et al., who reported
that 54 of 79 cases of SFT (68%) were found in theFigure 2 Macroscopic findings. (a) The resected specimen was 13 × 8 × 5
membrane and was elastic and hard. (b) A cross section revealed a solid tu
hemorrhagic focus.pleura [7]. SFT also arises in the retroperitoneal region
[2], as in our case, and has been reported in the eye
socket [3] and intracranial region [4]. Retroperitoneal
SFT is usually diagnosed by the presence of an abdomi-
nal distention or a palpable mass [2]. Pollakiuria has
been associated with SFT [8], as in our case, and it can
also be related to difficulty with urination [9].
Pathological analysis of SFT showed poorly differen-
tiated atypical tumor cells arranged in a random manner
in hyalinized collagen fibers (patternless pattern) or in a
hemangiopericytoma-like growth pattern [10]. Charac-
teristic immunohistochemical findings of SFT include
high positivity for CD34, which is known as the
fibroblast-related antigen. Positive results of immunohis-
tochemical testing for bcl-2 and vimentin and negative
results for c-kit are also helpful in the diagnosis of SFT
[10,11]. The tumor in this case demonstrated these char-
acteristics of SFT.
The first-line treatment for SFT is surgical resection.
Negative margins and complete surgical resection are.5 cm in size and 420 g in mass. The tumor was covered with a thick
mor with a grayish-white cut surface, a cystic component, and a
Figure 3 Histopathological findings. Oval or spindle cells in a random growth pattern with a collagenous matrix (hematoxylin–eosin staining).
(a) × 100, (b) × 200.
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spection should be performed to determine the ex-
tent of tumor invasion around the organs as well as
to ensure complete surgical resection and preserva-
tion of organ function. In this case, MRI was not
possible because a pacemaker had been implanted
previously. However, CE-CT revealed absence of
tumor invasion of other organs, lymph node swelling
and distal metastasis. Therefore complete resection
was performed.Figure 4 Immunohistochemical findings: The specimen was positive f
100; (b) bcl-2, × 100; (c) Vimentin, × 100; (d) c-kit, × 100.The World Health Organization classification of soft
tissue tumor in 2002 categorized extrapleural SFT as a
fibroblastic/myofibroblastic tumor of intermediate ma-
lignancy, which is defined as an ubiquitous mesenchymal
tumor of possible fibroblastic type with a prominent
hemangiopericytoma-like branching vascular pattern
[10]. Pathological characteristics of malignant SFT in-
clude hypercellular lesions, cytological atypia, numerous
mitoses (4 or more mitoses per 10 high-power fields),
tumor necrosis, and/or infiltrating margins [7,10-12].or CD34, bcl-2, and vimentin, but negative for c-kit. (a) CD34, ×
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92 cases of extrathoracic SFT, including local recurrence
or distal metastasis, in 7 of which at least one of the typ-
ical pathological characteristics was observed in the pri-
mary tumor [12].
Various benign or malignant soft tissue tumors emer-
ging from fat, muscle, and nerve may develop in the
retroperitoneal region [5]. Some retroperitoneal tumors
are diagnosed because of clinical symptoms or image
inspections. However, a definite diagnosis is difficult to
reach in many cases. Preoperative needle biopsy has
been reportedly useful in diagnosis of SFT [6]. However,
this technique carries the risk of peritoneal dissemin-
ation. Needle biopsy may be considered when complete
surgical resection is not possible because some retro-
peritoneal tumors, including malignant lymphoma
and malignant paraganglioma, may be sensitive to
chemotherapy [5].
Takazawa et al. reported no recurrence in patients
with SFT positive for both CD34 and bcl-2 [13]. Other
researchers reported a correlation between expression of
p53 and poor prognosis [6,14]. Yokoi et al. also found an
association between expression of p53 in malignant SFT
and poor prognosis, recurrence, nuclear atypia, high mi-
totic activity, and local invasion compared with that in
benign SFT [14]. They suggested a possible association
between p53 mutation and benign to malignant trans-
formation in SFT. Therefore, expression of CD34, bcl-2,
and p53 may be important in predicting the prognosis of
patients with SFT.
Conclusions
Complete surgical resection is the standard therapy for
SFT and pathologically negative margins are important
to achieve a good prognosis. Postoperative histochemical
analysis revealed no CD34, bcl-2, or p53 expression after
complete resection, and no atypical cells in the surgical
margins, suggesting good prognosis in our case. How-
ever, careful follow-up is necessary, since recurrence has
been reported more than 10 years after surgery in retro-
peritoneal SFT [15].
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